Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $3.99 | Day High | $4.00 | Day Low | $3.99 | |||
| Daily Volume | 14682 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $4.00 | 27498 | 0 | $4.04 | 27453 | |
Data source: Refinitiv
